Neonatal diabetes

Gene: RNU6ATAC

Amber List (moderate evidence)

RNU6ATAC (RNA, U6atac small nuclear (U12-dependent splicing))
EnsemblGeneIds (GRCh38): ENSG00000221676
EnsemblGeneIds (GRCh37): ENSG00000221676
OMIM: 601429, Gene2Phenotype
RNU6ATAC is in 1 panel

2 reviews

Ida Ertmanska (Genomics England Curator)

Green List (high evidence)

Comment on list classification: There are 7 individuals from 4 unrelated families with biallelic RNU6ATAC variants and early-onset diabetes (article not yet peer-reviewed). Hence, this gene will be recommended for promotion to Green on Neonatal diabetes panel once the article is published.
Created: 29 Dec 2025, 5:22 p.m. | Last Modified: 29 Dec 2025, 5:22 p.m.
Panel Version: 5.11
MedRxiv preprint Johnson et al., 2025 doi: https://doi.org/10.1101/2025.09.12.25335567
identified 19 individuals with early-onset diabetes (diagnosed <5 years) and additional clinical features who had biallelic pathogenic variants in the novel disease gene RNU6ATAC (n=7) or in RNU4ATAC (n=12). 12/19 had additional immune features of immune dysregulation.
Around 60% of patients also had microcephaly and developmental delay.

Among the 4 families with biallelic RNU6ATAC variants, the variants reported were: n.4T>C, n.6G>A, n.43G>A, n.68C>A, n.71C>T (homozygous or compound het).

RNU6ATAC has not yet been linked to any phenotypes in OMIM (accessed 29th Dec 2025).
Created: 29 Dec 2025, 5:21 p.m. | Last Modified: 29 Dec 2025, 5:22 p.m.
Panel Version: 5.11

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
neonatal diabetes mellitus, MONDO:0016391

Anna-Marie Johnson (Exeter Genomics Laboratory)

Green List (high evidence)

RNU6ATAC is a non-protein-coding gene and a component of the minor spliceosome, a protein-RNA complex mediating splicing of ~700 genes containing U12/minor-type introns. Johnson et al report RNU6ATAC as a novel disease gene causing monogenic autoimmune diabetes (median onset: 17 weeks) with additional immune dysregulation; whole genome sequencing of 4 individuals from 4 families identified 4 different biallelic pathogenic variants in the RNU6ATAC gene, all known causes of monogenic diabetes had already been excluded. Sanger sequencing of affected siblings from family A and D confirmed co segregation (1 additional case in family A, 2 in family D). RNA-seq from Family D confirmed intron retention in comparison to controls. Multi-omic analysis of patient samples revealed a profound B cell developmental defect.
Sources: Literature
Created: 11 Dec 2025, 8:31 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
neonatal diabetes; hypothyroidism; humoral immunue defect; hepatic disorder; growth failure; failure to thrive; skeletal abnormalities; atopic dermatitis; vitiligo; alopecia

Publications

  • MedRxiv preprint Johnson et al., 2025 https://doi.org/10.1101/2025.09.12.25335567

Mode of pathogenicity
Other

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
Phenotypes
  • neonatal diabetes mellitus, MONDO:0016391
  • hypothyroidism
  • humoral immunue defect
  • hepatic disorder
  • growth failure
  • failure to thrive
  • skeletal abnormalities
  • atopic dermatitis
  • vitiligo
  • alopecia
Tags
locus-type-rna-small-nuclear
OMIM
601429
Clinvar variants
Variants in RNU6ATAC
Penetrance
Complete
Publications
  • MedRxiv preprint Johnson et al., 2025 https://doi.org/10.1101/2025.09.12.25335567
Mode of Pathogenicity
Other
Panels with this gene

History Filter Activity

29 Dec 2025, Gel status: 2

Set Phenotypes

Ida Ertmanska (Genomics England Curator)

Phenotypes for gene: RNU6ATAC were changed from neonatal diabetes; hypothyroidism; humoral immunue defect; hepatic disorder; growth failure; failure to thrive; skeletal abnormalities; atopic dermatitis; vitiligo; alopecia to neonatal diabetes mellitus, MONDO:0016391; hypothyroidism; humoral immunue defect; hepatic disorder; growth failure; failure to thrive; skeletal abnormalities; atopic dermatitis; vitiligo; alopecia

29 Dec 2025, Gel status: 2

Entity classified by Genomics England curator

Ida Ertmanska (Genomics England Curator)

Gene: rnu6atac has been classified as Amber List (Moderate Evidence).

29 Dec 2025, Gel status: 0

Added Tag

Ida Ertmanska (Genomics England Curator)

Tag locus-type-rna-small-nuclear tag was added to gene: RNU6ATAC.

11 Dec 2025, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes, Set penetrance, Set mode of pathogenicity

Anna-Marie Johnson (Exeter Genomics Laboratory)

gene: RNU6ATAC was added gene: RNU6ATAC was added to Neonatal diabetes. Sources: Literature Mode of inheritance for gene: RNU6ATAC was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: RNU6ATAC were set to MedRxiv preprint Johnson et al., 2025 https://doi.org/10.1101/2025.09.12.25335567 Phenotypes for gene: RNU6ATAC were set to neonatal diabetes; hypothyroidism; humoral immunue defect; hepatic disorder; growth failure; failure to thrive; skeletal abnormalities; atopic dermatitis; vitiligo; alopecia Penetrance for gene: RNU6ATAC were set to Complete Mode of pathogenicity for gene: RNU6ATAC was set to Other Review for gene: RNU6ATAC was set to GREEN